Sponsor	NOVARTIS
Subject	Individualizing therapy to optimize outcomes in AMD
Time	12:40-13:40
Venue	Room 10
Chairs	Ha Kyoung KIM Masahito OHJI
Speakers	Adrian KOH Brendan VOTE Tzung-Dau WANG
Synopsis	Evidence-based AMD treatment guideline with Lucentis; Longterm efficacy data and the pharmacological aspects of VEGF inhibition with long term safety data